Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹12,603 Cr
Revenue (TTM)
₹1,284 Cr
Net Profit (TTM)
₹134 Cr
ROE
30.7 %
ROCE
27 %
P/E Ratio
93.8
P/B Ratio
10.3
Industry P/E
34.72
EV/EBITDA
48.4
Div. Yield
0 %
Debt to Equity
0.8
Book Value
₹33.4
EPS
₹8.7
Face value
1
Shares outstanding
164,750,309
CFO
₹202.28 Cr
EBITDA
₹616.85 Cr
Net Profit
₹242.23 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rubicon Research
| 13.5 | -2.5 | 17.8 | -- | -- | -- | -- |
|
BSE Healthcare
| -2.5 | -1.6 | -3.7 | 3.3 | 25.3 | 15.6 | 10.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rubicon Research
|
772.4 | 12,602.6 | 1,284.3 | 134.4 | -- | 30.7 | 93.8 | 10.3 |
| 2,356.5 | 18,879.5 | 1,215.1 | 284.8 | 28.7 | 21.1 | 65.8 | 12.4 | |
| 663.9 | 13,060.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.8 | 2.4 | |
| 592.4 | 14,620.0 | 5,092.5 | 545.5 | 15.9 | 14.1 | 26.8 | 3.5 | |
| 848.3 | 13,554.0 | 7,918.4 | 429.9 | 10.7 | 7.2 | 31.3 | 2.0 | |
| 963.6 | 17,210.7 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.1 | 2.0 | |
| 1,492.5 | 16,884.9 | 1,419.3 | 20.1 | 8.4 | 0.5 | 840 | 2.9 | |
| 138.2 | 18,243.9 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.3 | |
| 414.0 | 16,617.2 | 3,720.2 | 352.1 | 13.7 | 8.2 | 47.2 | 3.5 | |
| 1,194.7 | 19,671.3 | 3,151.0 | -10.0 | 8.4 | 2.5 | 894.2 | 4.3 |
No Review & Analysis are available.
--
Incorporated
1999
Chairman
--
Managing Director
Pratibha Sudhir Pilgaonkar
Headquarters
Thane, Maharashtra
Website
Looking for more details about Rubicon Research Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Rubicon Research Ltd is ₹772.40 (NSE) and ₹772.00 (BSE) as of 20-Mar-2026 11:19 IST. Rubicon Research Ltd has given a return of --% in the last 1 years.
The P/E ratio of Rubicon Research Ltd is 93.80 times as on 20-Mar-2026, a 170 premium to its peers’ median range of 34.72 times.
The P/B ratio of Rubicon Research Ltd is 10.34 times as on 20-Mar-2026, a 244 premium to its peers’ median range of 3.01 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Rubicon Research Ltd are Rs 822.00 and Rs 570.75 as of 20-Mar-2026.
Rubicon Research Ltd has a market capitalisation of ₹ 12,603 Cr as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Rubicon Research Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹14.95
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.